Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAXGlobeNewsWire • 07/21/22
Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public OfferingGlobeNewsWire • 07/21/22